DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol ▲ | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0041948 | Uremia | ATRNL1 | 26033 | attractin like 1 | Q5VV63 |
C0600139 | Prostate carcinoma | ATRNL1 | 26033 | attractin like 1 | Q5VV63 |
C0023890 | Liver Cirrhosis | ATRNL1 | 26033 | attractin like 1 | Q5VV63 |
C0376358 | Malignant neoplasm of prostate | ATRNL1 | 26033 | attractin like 1 | Q5VV63 |
C0027651 | Neoplasms | ATRNL1 | 26033 | attractin like 1 | Q5VV63 |
C0678222 | Breast Carcinoma | ATRNL1 | 26033 | attractin like 1 | Q5VV63 |
C0345904 | Malignant neoplasm of liver | ATRNL1 | 26033 | attractin like 1 | Q5VV63 |
C0524851 | Neurodegenerative Disorders | ATRNL1 | 26033 | attractin like 1 | Q5VV63 |
C0002395 | Alzheimer's Disease | ATRNL1 | 26033 | attractin like 1 | Q5VV63 |
C0009806 | Constipation | ATRNL1 | 26033 | attractin like 1 | Q5VV63 |
C0205823 | Pleomorphic Lipoma | ATRNL1 | 26033 | attractin like 1 | Q5VV63 |
C1837218 | Cleft palate, isolated | ATRNL1 | 26033 | attractin like 1 | Q5VV63 |
C0020619 | Hypogonadism | ATRNL1 | 26033 | attractin like 1 | Q5VV63 |
C0007131 | Non-Small Cell Lung Carcinoma | B3GALNT1 | 8706 | beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) | O75752 |
C0027651 | Neoplasms | B3GALNT1 | 8706 | beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) | O75752 |
C1335302 | Pancreatic Ductal Adenocarcinoma | B3GALNT1 | 8706 | beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) | O75752 |
C0006118 | Brain Neoplasms | B3GALNT1 | 8706 | beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) | O75752 |
C3665347 | Visual Impairment | B3GALNT2 | 148789 | beta-1,3-N-acetylgalactosaminyltransferase 2 | Q8NCR0 |
C0027092 | Myopia | B3GALNT2 | 148789 | beta-1,3-N-acetylgalactosaminyltransferase 2 | Q8NCR0 |
C0026850 | Muscular Dystrophy | B3GALNT2 | 148789 | beta-1,3-N-acetylgalactosaminyltransferase 2 | Q8NCR0 |
C0018784 | Sensorineural Hearing Loss (disorder) | B3GALNT2 | 148789 | beta-1,3-N-acetylgalactosaminyltransferase 2 | Q8NCR0 |
C0854723 | Retinal Dystrophies | B3GALNT2 | 148789 | beta-1,3-N-acetylgalactosaminyltransferase 2 | Q8NCR0 |
C0241005 | Creatine phosphokinase serum increased | B3GALNT2 | 148789 | beta-1,3-N-acetylgalactosaminyltransferase 2 | Q8NCR0 |
C3554638 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11 | B3GALNT2 | 148789 | beta-1,3-N-acetylgalactosaminyltransferase 2 | Q8NCR0 |
C0086543 | Cataract | B3GALNT2 | 148789 | beta-1,3-N-acetylgalactosaminyltransferase 2 | Q8NCR0 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024